Literature DB >> 10051569

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

P A Kratz1, B Böttcher, M Nassal.   

Abstract

The nucleocapsid of hepatitis B virus (HBV), or HBcAg, is a highly symmetric structure formed by multiple dimers of a single core protein that contains potent T helper epitopes in its 183-aa sequence. Both factors make HBcAg an unusually strong immunogen and an attractive candidate as a carrier for foreign epitopes. The immunodominant c/e1 epitope on the capsid has been suggested as a superior location to convey high immunogenicity to a heterologous sequence. Because of its central position, however, any c/e1 insert disrupts the core protein's primary sequence; hence, only peptides, or rather small protein fragments seemed to be compatible with particle formation. According to recent structural data, the epitope is located at the tips of prominent surface spikes formed by the very stable dimer interfaces. We therefore reasoned that much larger inserts might be tolerated, provided the individual parts of a corresponding fusion protein could fold independently. Using the green fluorescent protein (GFP) as a model insert, we show that the chimeric protein efficiently forms fluorescent particles; hence, all of its structurally important parts must be properly folded. We also demonstrate that the GFP domains are surface-exposed and that the chimeric particles elicit a potent humoral response against native GFP. Hence, proteins of at least up to 238 aa can be natively displayed on the surface of HBV core particles. Such chimeras may not only be useful as vaccines but may also open the way for high resolution structural analyses of nonassembling proteins by electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051569      PMCID: PMC26711          DOI: 10.1073/pnas.96.5.1915

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization.

Authors:  M Nassal
Journal:  Gene       Date:  1988-06-30       Impact factor: 3.688

Review 2.  High-resolution icosahedral reconstruction: fulfilling the promise of cryo-electron microscopy.

Authors:  E J Mancini; F de Haas; S D Fuller
Journal:  Structure       Date:  1997-06-15       Impact factor: 5.006

3.  Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.

Authors:  F Birnbaum; M Nassal
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.

Authors:  J Salfeld; E Pfaff; M Noah; H Schaller
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy.

Authors:  B Böttcher; S A Wynne; R A Crowther
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

7.  Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.

Authors:  M Sällberg; U Rudén; L O Magnius; H P Harthus; M Noah; B Wahren
Journal:  J Med Virol       Date:  1991-04       Impact factor: 2.327

8.  The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Authors:  F Schödel; A M Moriarty; D L Peterson; J A Zheng; J L Hughes; H Will; D J Leturcq; J S McGee; D R Milich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

Authors:  D R Milich; A McLachlan
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

10.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

View more
  83 in total

1.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Efficient and stable display of functional proteins on bacterial magnetic particles using mms13 as a novel anchor molecule.

Authors:  Tomoko Yoshino; Tadashi Matsunaga
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 3.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.

Authors:  Andreas Walker; Claudia Skamel; Jolanta Vorreiter; Michael Nassal
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

5.  Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.

Authors:  Katleen Broos; Michiel E Janssens; Ine De Goeyse; Peter Vanlandschoot; Geert Leroux-Roels; Dirk Geysen; Yves Guisez
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

6.  Single hepatitis-B virus core capsid binding to individual nuclear pore complexes in Hela cells.

Authors:  Yoriko Lill; Markus A Lill; Birthe Fahrenkrog; Kyrill Schwarz-Herion; Sara Paulillo; Ueli Aebi; Bert Hecht
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

7.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

8.  Development of a reverse genetic system for infectious salmon anemia virus: rescue of recombinant fluorescent virus by using salmon internal transcribed spacer region 1 as a novel promoter.

Authors:  Daniela Toro-Ascuy; Carolina Tambley; Carolina Beltran; Carolina Mascayano; Nicolas Sandoval; Eduardo Olivares; Rafael A Medina; Eugenio Spencer; Marcelo Cortez-San Martín
Journal:  Appl Environ Microbiol       Date:  2015-02       Impact factor: 4.792

Review 9.  Development of imaging scaffolds for cryo-electron microscopy.

Authors:  Todd O Yeates; Matthew P Agdanowski; Yuxi Liu
Journal:  Curr Opin Struct Biol       Date:  2020-02-14       Impact factor: 6.809

10.  Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.

Authors:  Marko Roblek; Stefan Schüchner; Veronika Huber; Katrin Ollram; Sylvia Vlcek-Vesely; Roland Foisner; Manfed Wehnert; Egon Ogris
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.